HIV-1 Clones with Attenuated Cytopathic Effects
HIV-1 Clones with Attenuated Cytopathic Effects
批准号:
6655454
负责人:
DAVID CAMERINI
金额:
$22.73万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2005-04-30
中文摘要
描述(由申请人提供):艾滋病毒在感染者中的致病机制和组织培养中的细胞病变效应与病毒载量和复制密切相关。我们建议研究几个独特的具有减弱细胞病变效应(CPE)的HIV-1克隆,这些克隆来自高病毒载量的长期非进展者,这将使我们能够将病毒载量和复制的决定因素与HIV-1致病的决定因素分开。大多数来自长期非进展者(LTNP)的HIV-1分离株是CCR5嗜性(R5),在体内和组织培养中复制能力很差,相比之下,一些LTNP矛盾地具有中到高的病毒载量(LTNP-HVL),相当于进展为艾滋病的个体。我们假设并有初步数据表明,一些LTNP-HVL来源的HIV-1克隆与进展为艾滋病的人的HIV-1克隆相比,具有同等的复制能力,但细胞病变程度较低。本申请中提出的研究将使用这些独特的克隆来确定所有HIV-1克隆的遗传决定因素和致病机制。这些独特的HIV-1克隆可能使我们将病毒致病的决定因素与病毒复制的决定因素分开,这可能会影响艾滋病治疗和疫苗的发展。1.研究LTNP-HVL分离株R5株HIV-1在FTOC、扁桃体组织培养和SCID-Hu小鼠体内的复制和细胞病变效应。我们将进一步鉴定我们已经开始研究的两个具有减毒CPE的HIV-1克隆,并将在FTOC和扁桃体组织培养中至少再鉴定两个这些独特的和信息丰富的HIV-1生物克隆。最弱的HIV-1克隆也将在SCID-Hu小鼠身上进行研究。2.组织培养鉴定来自LTNP-HVL的R5株HIV-1分离株的Env和Nef相关表型。这些表型将被研究,因为它们与HIV-1的发病机制有关,因为它们在进展者和非进展者以及从感染早期到晚期的HIV-1克隆之间存在差异。
英文摘要
DESCRIPTION (provided by applicant): HIV pathogenesis in infected individuals and cytopathic effects in tissue culture are tightly correlated with viral load and replication. We propose to study several unique HIV-1 clones with attenuated cytopathic effects (CPE) derived from long term non progressors with high viral load, which will allow us to separate the determinants of viral load and replication from the determinants of HIV-1 pathogenesis. Most HIV-1 isolates from long-term non-progressors (LTNP) are CCR5-tropic (R5) and replicate poorly in vivo and in tissue culture, in contrast, some LTNP paradoxically have moderate to high viral load (LTNP-HVL), equivalent to that seen in individuals who progress to AIDS. We hypothesize and have preliminary data which indicate, that some LTNP-HVL derived HIV-1 clones are equally replication competent but less cytopathic than HIV-1 clones from individuals who progress to AIDS. The studies proposed in this application will use these unique clones to define the genetic determinants and mechanisms of pathogenesis of all HIV-1 clones. These unique HIV-1 clones may allow us to separate determinants of viral pathogenesis from determinants of viral replication, which may impact the development of AIDS therapeutics and vaccines. We have the following specific aims: 1. Characterize the replication and cytopathic effects, of R5 HIV-1 isolates from LTNP-HVL in FTOC, tonsil histoculture and SCID-hu mice. We will further characterize two HIV-1 clones with attenuated CPE that we have started to study and will characterize at least two more of these unique and informative HIV-1 biological clones in FTOC and tonsil histoculture. The most attenuated HIV-1 clones will also be studied in SCID-hu mice. 2. Characterize the Env and Nef associated phenotypes of R5 HIV-1 isolates from LTNP-HVL in tissue culture. These phenotypes will be studied since they have been linked to pathogenesis of HIV-1 due to their variation between HIV-1 clones from progressors and non-progressors and from early to late stages of infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
-
批准号:10259177
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2021
-
负责人:DAVID CAMERINI
-
依托单位:
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
-
批准号:9467246
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2018
-
负责人:DAVID CAMERINI
-
依托单位:
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus
-
批准号:9347926
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:DAVID CAMERINI
-
依托单位:
Point of Care Detection of Oral Pathogens
-
批准号:8973923
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:DAVID CAMERINI
-
依托单位:
Development of a Pan-HIV Proteomic Chip
-
批准号:8659860
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:DAVID CAMERINI
-
依托单位:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
-
批准号:8069963
-
项目类别:
-
资助金额:$18.97万
-
财政年份:2010
-
负责人:DAVID CAMERINI
-
依托单位:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
-
批准号:7931065
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2010
-
负责人:DAVID CAMERINI
-
依托单位:
Defensin mediated inhibition of HIV-1 replication
-
批准号:6954219
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2004
-
负责人:DAVID CAMERINI
-
依托单位:
Defensin mediated inhibition of HIV-1 replication
-
批准号:6845911
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2004
-
负责人:DAVID CAMERINI
-
依托单位:
HIV-1 Clones with Attenuated Cytopathic Effects
-
批准号:6744170
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2003
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6374535
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6608017
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6740219
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6511307
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6213536
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
PATHOGENESIS OF R5 HIV-1 ISOLATES
-
批准号:6554505
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2000
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2429507
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:6169936
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2672777
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICE
-
批准号:2076892
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:DAVID CAMERINI
-
依托单位:
海外基金